Skip to main content

Balchem Corporation Value Stock - Dividend - Research Selection

Balchem corporation

ISIN: US0576652004 , WKN: 905650

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets in the United States and internationally. It operates through three segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment also offers microencapsulation solutions; and human grade choline nutrients and mineral amino acid chelated products for wellness applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment offers ethylene oxide primarily for use in the health care industry; and single use canisters with ethylene oxide for sterilizing re-usable devices. This segment also sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. The company sells its products through sales force, independent distributors, and sales agents. Balchem Corporation was incorporated in 1967 and is headquartered in New Hampton, New York.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


Snowflake To Rally Around 16%? Here Are 10 Top Analyst Forecasts For Monday

2026-08-03
Top Wall Street analysts changed their outlook on top names. Barclays raised DAR's target to $65, BTIG boosted SNOW's target to $340, and JP Morgan upgraded LYB to Overweight.

HC Wainwright & Co. Maintains Buy on Balchem, Raises Price Target to $215

2026-08-03
HC Wainwright & Co. analyst Raghuram Selvaraju maintains Balchem (NASDAQ:BCPC) with a Buy and raises the price target from $190 to $215.

Balchem: It's A Buy From Me After Posting Strong Q2 Results

2026-08-01

Balchem Corporation (BCPC) Q2 2026 Earnings Call Transcript

2026-07-31
Balchem Corporation (BCPC) Q2 2026 Earnings Call July 31, 2026 11:00 AM EDTCompany ParticipantsCarl Bengtsson - Executive VP, CFO, Treasurer and GM of...

Balchem (NASDAQ:BCPC) Beats Q2 Estimates as Record Sales and Adjusted EPS Top Expectations

2026-07-31
Balchem Q2 earnings beat estimates with record sales and EPS, but stock reaction muted amid lacking guidance.

Balchem Corporation 2026 Q2 - Results - Earnings Call Presentation

2026-07-31
2026-07-31. The following slide deck was published by Balchem Corporation in conjunction with their 2026 Q2 earnings call.

Conestoga SMid Cap Composite Q2 2026 Portfolio Review

2026-07-31
We were attracted to Knowles' accelerating organic growth, expanding margins, and exposure to several attractive long-term secular trends.

Balchem Q2 Adj. EPS $1.49 Beats $1.40 Estimate, Sales $283.997M Beat $268.502M Estimate

2026-07-31
Balchem (NASDAQ:BCPC) reported quarterly earnings of $1.49 per share which beat the analyst consensus estimate of $1.40 by 6.43 percent. This is a 17.32 percent increase over earnings of $1.27 per share from the same

Conestoga Small Cap Composite Q2 2026 Portfolio Activity

2026-07-29
DGII stock moved higher after the company reported record revenue and continued progress shifting toward a more recurring revenue-oriented business model.

Balchem Corporation Announces Quarterly Conference Call for Second Quarter 2026 Financial Results on July 31, 2026

2026-07-17
MONTVALE, N.J., July 17, 2026 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) today announced that a conference call will be held on Friday, July 31, 2026, at 11:00 AM Eastern Time (ET) to review second quarter results. Ted Harris, Chairman of the Board, President and CEO, and Martin Bengtsson, CFO, will host the call. Second quarter results will be published prior to the market opening on Friday, July 31, 2026. The press release, and its accompanying financial exhibits, will also be avai